You just read:

Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl

News provided by

Anthera Pharmaceuticals, Inc.

Apr 18, 2011, 08:00 ET